<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Brighton and Sussex Medical School</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F75103EE-8294-429F-BC9F-70CBED7DA893"><gtr:id>F75103EE-8294-429F-BC9F-70CBED7DA893</gtr:id><gtr:name>St Jude Children's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6801518B-C8E0-47A7-B97F-836705903CA0"><gtr:id>6801518B-C8E0-47A7-B97F-836705903CA0</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Caldecott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901606"><gtr:id>FFC1CECD-A3E3-4046-88AE-F0C747F74BB5</gtr:id><gtr:title>Characterisation of a Novel Human Tyrosyl DNA phosphodiesterase</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901606</gtr:grantReference><gtr:abstractText>Human cells possess a class of proteins known as topoisomerases that stop DNA from becoming twisted or overwound. Occassionally, these proteins accidentally break DNA and thereby render our genetic material unstable. If not repaired properly, such DNA breaks can lead to cell death or cancer. Here, we have identified a completely novel human enzyme that can safeguard DNA against topoisomerase-induced DNA damage by repairing these breaks if they arise. We now wish to characterise the function of this novel human enzyme in detail, and investigate its importance to DNA stability and human health.</gtr:abstractText><gtr:technicalSummary>Topoisomerases regulate DNA topology and are fundamental to many aspects of chromosome metabolism. However, topoisomerase activity involves the transient cleavage of DNA, which if occurring close to sites of endogenous DNA damage or in the presence of topoisomerase poisons can result in abortive topoisomerase-induced DNA single- or double-strand breaks that threaten genome integrity. A characteristic feature of topoisomerase-induced DNA breaks is covalent linkage of the enzyme to DNA termini via a 3?- or 5?-phosphotyrosyl bond. Such breaks are implicated in hereditary human disease, chromosomal instability and cancer, and underlie the clinical efficacy of an important class of anti-tumour poisons. The importance of liberating DNA termini from trapped topoisomerase is illustrated by the progressive neurodegenerative disease observed in individuals harbouring a mutation in tyrosyl DNA phosphodiesterase-1 (TDP1), an enzyme that cleaves 3?-phosphotyrosyl bonds. Surprisingly, however, a complementary human enzyme that cleaves 5?-phosphotyrosyl bonds has not been reported, despite the impact of DNA double-strand breaks harbouring such termini on chromosome instability and cancer. Here, we identify such an enzyme and reveal that this enzyme is TTRAP, a member of the metal-dependent family of phosphodiesterases of unknown function. TTRAP is the first human 5?-tyrosyl DNA phosphodiesterase to be identified, and we propose that this enzyme facilitates the repair of DNA strand breaks arising from abortive topoisomerase activity and is thereby important for genetic stability and proper neural function, in vivo.</gtr:technicalSummary><gtr:fund><gtr:end>2013-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>364219</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>St Jude Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>McKinnon and Mouse Models</gtr:description><gtr:id>243FE166-387D-4EFA-8593-1E69A914976C</gtr:id><gtr:impact>This collaboration was crucial in the development of my laboratory - allowing me to introduce mouse model systems into my programme of work. This was a critical aspect of the work currently being conducted under the auspices of my current MRC programme grant (G0600776). The sabbatical period for my student (Sherif F El Khamisy) also provided the experience necessary for him to deveop his own research laboratory, with subsequent funding from the Wellcome Trust. Several publications have emerged from this collaboration - one of which was financially supported by this grant (17914460)and two (19303373 &amp;amp; 19633665) that were supported by my current MRC programme grant (G0600776).</gtr:impact><gtr:outcomeId>1EB99994E03-1</gtr:outcomeId><gtr:partnerContribution>This collaboration enabled my group to introduce expertise in mouse model systmes into our work. This was necessary to progress our research into the link between single-strand break repair and neurodegenerative diseases.</gtr:partnerContribution><gtr:piContribution>My group provided expertise in the cellular analysis of single-strand break repair, and manpower (including a sabbatical period for one of my students)</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Centenary Exhibition</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>03215E0C-6FA9-4B15-9BFA-4BFC4454E338</gtr:id><gtr:impact>local school teachers/colleges and students/pupils visited a day of presentations on our research and its importance for health,culminating in several keynote talks that sparked discussion and conversation

this has encouraged further interest in our work experience week</gtr:impact><gtr:outcomeId>SzM7q5yeGbT</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience 2010-2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7CCDF827-504A-413D-854B-EEA7FC1F72A6</gtr:id><gtr:impact>Each year I host and organise a work experience week in for four-six children/yr from several local schools. During the week, the children participate in a variety of different scientific experiments in several different laboratories, with the intention of illustrating what a career in science is like.

schools typically receive great feedback from the students, who seem to enjoy the experience. This year, one school has also asked me to contribute to a career &amp;quot;speed dating&amp;quot; event in Jan 2013</gtr:impact><gtr:outcomeId>qQxSdK4T3gQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant (2013)</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>A85ECC0E-2769-402A-8223-109A88BE7B19</gtr:id><gtr:outcomeId>kq3tdK9PaVb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>input into MRC strategy via MCMB</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83CE150A-830E-4EE0-B797-30A79D23AA02</gtr:id><gtr:outcomeId>auftbfbwBoM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>86A2BA54-3681-4AB4-8221-5111257EF59C</gtr:id><gtr:title>Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesterase.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dae7ee13f87986659406279e5611c092"><gtr:id>dae7ee13f87986659406279e5611c092</gtr:id><gtr:otherNames>Thomson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>pm_15157_27_23416181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2952BFAC-D1C3-49FC-B5CA-9ECEDFDE7451</gtr:id><gtr:title>TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02a111a9043650e30f5eae331d4f2c9b"><gtr:id>02a111a9043650e30f5eae331d4f2c9b</gtr:id><gtr:otherNames>Zeng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>UA2RRrD5STh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61EA764A-1825-4DE5-9B53-26F93C1D4A50</gtr:id><gtr:title>Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0882a5a13e222d581304082cabadab3f"><gtr:id>0882a5a13e222d581304082cabadab3f</gtr:id><gtr:otherNames>Raoof A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>545c02db16a8c7.58677250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06546486-ADEE-4555-A656-AE4527A23D69</gtr:id><gtr:title>TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cffc1dcecc4c0baa2ac7d37b3dd34adf"><gtr:id>cffc1dcecc4c0baa2ac7d37b3dd34adf</gtr:id><gtr:otherNames>G?mez-Herreros F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_15157_27_23505375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EDD1843-BE60-4493-9EEE-79F5306A7B15</gtr:id><gtr:title>Tyrosyl DNA phosphodiesterase 2, an enzyme fit for purpose.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df98d3748be077b8e6cd59725a036bdb"><gtr:id>df98d3748be077b8e6cd59725a036bdb</gtr:id><gtr:otherNames>Caldecott KW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15157_27_23211766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52C3FD23-F014-46BB-8FCA-AF9BD70A6CAA</gtr:id><gtr:title>A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b7a8f49066d9d4de3c7eaacf0ad7ff8"><gtr:id>7b7a8f49066d9d4de3c7eaacf0ad7ff8</gtr:id><gtr:otherNames>Cortes Ledesma F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>sz45L51AJ4x</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901606</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>